Understanding the Effects of the mRNA Vaccine
Explore the findings of a paper from Dr. Mark Davis' group that shows the effects of the mRNA vaccine on CD8 T cell responses in people who had prior COVID compared to uninfected people. Learn about the use of SARS-CoV-2 pMHC-spheromers to detect viral antigen-specific CD8 and CD4 T cells.
Prof. Akiko Iwasaki
We study innate and adaptive immunity against viruses and study disease pathogenesis. #COVID19 #longCOVID #vaccines @HHMINEWS @YaleIBIO @YaleMed @YaleCII
-
A very interesting paper from Dr. Mark Davis’ group shows that in response to the mRNA vaccine, CD8 T cell responses are attenuated in people who had prior COVID compared to uninfected people. What does this mean? (1/)https://t.co/thiEOpgUA9
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Fei Gao, @VMallajosyula et al used SARS-CoV-2 pMHC-spheromers to detect viral antigen-specific CD8 and CD4 T cells from people who were vaccinated, infected or both. Spheromers are peptide-MHC multimers (12 units) that are more sensitive than conventional pMHC tetramers. (2/) pic.twitter.com/WckDq7dNen
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
CD8 T cell responses to viral antigens were compared in people who received the mRNA vaccines to those with prior infection with SARS-CoV-2. The vaccine induced significantly better CD8 T cell immunity in both quantity and quality than the infection. (3/) pic.twitter.com/WmOgPcEn8d
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Notably, people who recovered from COVID and then were vaccinated had much lower CD8 T cell response than people who were not infected (naive) and vaccinated. The CD8 T cells’ ability to secrete cytokines and become activated was also poorer in the recovered group. (4/) pic.twitter.com/kjuNjTzkkM
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Why does infection induce poorer CD8 T cell immunity than the vaccine? The answer may be related to the ability of this virus to impair MHC I presentation (5/)https://t.co/IRZBcAU8T7https://t.co/HXszC6dUIghttps://t.co/96Y73jTSFfhttps://t.co/lwTqLZVe5K
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Why does prior infection impair CD8 T cell responses induced by the mRNA vaccine? This may imply induction of some form of regulatory immune response by the infection, or sequestration of Spike by preexisting antibodies for MHC I presentation. (6/)
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Does this mean that prior infection with COVID will render people susceptible to future reinfections? Not necessarily. We know that prior infection promotes better neutralizing antibody responses after vaccination - the best correlate of protection. (7/)https://t.co/0gvlaZHorJ pic.twitter.com/C8oRb7J2zS
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Does the study by Gao et al mean that prior COVID will make people immunodeficient (unable to fight any infection)? Not likely based on other data. @JohngLab found enhanced (not lower) immunity to flu vaccine in men who recovered from mild COVID. (8/)https://t.co/3ZtUmpJyoq
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Could impaired CD8 T cell immunity lead to long COVID? Possibly - by enabling the SARS-CoV-2 infection to persist or by enabling reinfections to be more productive. But this hypothesis must be tested. A great paper with much to think about. (End)
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023 -
Oops, wrong handle! @TsangLab 👆🏼 Sorry!
— Prof. Akiko Iwasaki (@VirusesImmunity) March 21, 2023